SenzaGen’s tests identify potentially harmful chemicals. It is more relevant and cost-efficient, making animal testing unnecessary and daily products safer.

GLP Compliant Laboratory

Skin sensitization

GARD®skin and GARD®skin Medical Device are robust in vitro assays to identify potential chemical skin sensitizers with over 90% prediction accuracy.

Skin potency classification

GARD®potency is an add-on in vitro test to GARDskin for potency classification according to GHS/CLP (1A or 1B).

Respiratory sensitization

GARD®air is the first in vitro assay capable of identifying chemical respiratory sensitizers. It can be used alone or in combination with GARDskin to discriminate between respiratory and skin sensitizers.

Press Releases

14 Dec, 2017
Regulatory
English
IR
News
Other Corporate Information
MAR
Corporate Information
08 Sep, 2017
IR
Corporate Information
English
Other Corporate Information
News

Subscribe


Prenumerera